CRISM

Lancement virtuel : À la rencontre de la relation d'aide difficile
2020-11-16 12:00 - 13:00 (America/New_York)
Les Presses de l’Université Laval vous invitent au lancement virtuel du livre « À la rencontre de la relation d’aide difficile » sous la direction de Michel T. Giroux qui se tiendra le lundi 16 novembre à 12h sur la plateforme Zoom.
Le livre:
Le lecteur découvrira à la fois un exposé théorique fondamental en psychologie et des instruments pratiques destinés au professionnel déstabilisé qui souhaite voir clair en lui-même. Des notions capitales en éthique clinique présentent au professionnel des instruments intellectuels qui lui permettent de donner un sens à sa conduite. Les études de cas sur des relations d’aide difficiles montrent comment la dimension clinique, le droit et l’éthique peuvent être utilisés dans la réflexion du professionnel.
Les collaborateurs:

André Renaud: Psychologue et psychanalyste en pratique privée;
Michelle Boivin: Travailleuse sociale et coordonnatrice clinique à l’I.R.D.P.Q.;
Claude Maheux: Médecin retraité du CHU de Québec-Université Laval;
Anne-Marie Savard: Juriste et professeure à la Faculté de droit Université Laval;
Sylvain Auclair: Professeur de philosophie au Cégep de Sainte-Foy;
Marie-Ève Bouthillier: Éthicienne clinique à l’Unité d’éthique clinique de l’Hôpital de la Cité-de-la-Santé, Laval;
Suzanne Brissette: Médecin, chef du service de médecine des toxicomanies, CHUM;
Delphine Roigt: Chargée d’enseignement de clinique, Département de médecine familiale et d’urgence à la Faculté de médecine – Université de Montréal;
Bruno Hébert: professeur de philosophie à la retraite, artiste peintre et écrivain.

Inscrivez-vous gratuitement!

Élimination de l’hépatite C : soutenir la réponse canadienne pendant et après la COVID-19
2020-11-25 12:00 - 13:30
Webinaire en français organisé par CATIE en partenariat avec CanHepC portant sur les implications de la COVID-19 sur les efforts d’élimination et pour les personnes vivant avec le VHC. Avec la participation du Dre Marina Klein, du Dre Julie Bruneau et du Dr Brian Conway.

Webinar on the Guidance Documents on Substance Use and COVID-19
2021-02-05 13:00 - 14:00
Friday 5, 2021 – 1pm to 2pm EST
Calendar entry.
At the request of the Government of Canada, the Canadian Research Initiative in Substance Misuse (CRISM) developed 6 national guidance documents that address the urgent needs of people who use substances, as well as service providers and decision makers during the COVID-19 pandemic.
As part of a knowledge dissemination approach, Health Canada will be hosting a webinar, led by one of CRISM’s investigators Dr. Tara Elton-Marshall, to provide an overview of the 6 guidance documents as well as other rapid response projects related to substance use and COVID-19 such as the qualitative survey of the impact of COVID-19 on People with Living Experience of Drug Use.
Dr. Elton-Marshall is an Independent Scientist and a Co-Section Head of the Population Health and Community Transformation (PHACT) section in the Institute for Mental Health Policy Research (IMHPR) at CAMH, an Assistant Professor (status only) at the University of Toronto and an adjunct Associate Professor at Western University. She is a Co-PI on the Ontario Node of the Canadian Research Initiative in Substance Misuse (CRISM), a strategic initiative funded by CIHR. CRISM is a national network of researchers, service providers, policy makers and people with lived experience across Canada. The goal of CRISM is to conduct and translate evidence-based interventions for substance misuse to improve the health care system.
Please note, the guidance provided in the documents is subject to change as new information becomes available and the pandemic and public health responses evolve over time.
We invite you to extend this invitation to other stakeholders that you feel would benefit from this webinar. Please note that this webinar will be presented in English however a French webinar on the guidelines will be held at a later date in February 2021.
CRISM is available to present additional webinars on each of the 6 topic areas. If you are interested in additional webinars, you can indicate your interest by completing the survey found at: https://www.surveymonkey.com/r/7YD9N2K.
Webex Online Meeting Information

Go to https://canada.webex.com/canada/j.php?MTID=m73ed58de93e1517b962eaacfdd466f76 the day of the webinar
Enter your name and email address.
Enter the meeting password: [REDACTED]
Follow the instructions that appear on your screen

Teleconference dial-in (If not using web audio)

Toll Free 1-855-288-0982
Toll Free 2 1-855-244-8677
Access Code: 179 591 1771

Événement virtuel sur la crise des surdoses : Des données aux actions
2021-02-17 13:00 - 15:00
Programmation détaillée

Mise en contexte de la situation des surdoses au Québec
Qu’est-ce qui circule dans le marché illicite au Québec et ce que ces données nous révèlent ?
La pharmacothérapie de remplacement au Québec
Présentation de l’outil Reconnaître et agir de l’Équipe de soutien clinique et organisationnel en dépendance et itinérance

Public cible
Pour les professionnels du réseau de la santé et des services sociaux ainsi que du milieu communautaire.

Conférencièr.e.s

Thierry Lefrançois, Superviseur au Service d’analyse des drogues, Direction générale des opérations réglementaires et de l’application de la loi, Santé Canada
Dre Marie-Ève Goyer, Directrice scientifique, Équipe de soutien clinique et organisationnel en dépendance et itinérance, IUD
Jérôme Benedetti, Assistant de recherche, Équipe de soutien clinique et organisationnel en dépendance et itinérance, IUD
Karine Hudon, Coordonnatrice, Équipe de soutien clinique et organisationnel en dépendance et itinérance, IUD

Une opportunité à saisir : Implanter un centre de prévention des surdoses

Les différents types de site de consommation, avec la participation de Richard Cloutier, DGSP, MSSS
Capsules vidéo: Portrait de 3 centres de prévention des surdoses du Québec
Boîte à outils pour soutenir l’implantation d’un centre de prévention des surdoses au Québec de l’Équipe de soutien clinique et organisationnel en dépendance et itinérance

Inscription gratuite mais obligatoire.

Stimulus Connect 10: Impact of the Pandemic on People Who Use Drugs
2021-02-18 13:00 - 15:00
10am – noon Pacific 11am – 1pm Mountain 12-2pm Central 1-3pm Eastern 2-4pm Atlantic 2:30-4:30pm Newfoundland & Labrador
Public health in Canada responded dramatically to the COVID-19 crisis and not the overdose crisis. Join us for the Impact of the Pandemic on People Who Use Drugs: Part 1 as we connect.

Webinar on the Guidance Documents on Substance Use and COVID-19
2021-02-24 12:00 - 13:00
At the request of the Government of Canada, the Canadian Research Initiative in Substance Misuse (CRISM) developed 6 national guidance documents that address the urgent needs of people who use substances, as well as service providers and decision makers during the COVID-19 pandemic.
Health Canada and CRISM will be hosting a webinar, led by Dr. Julie Bruneau, to provide an overview of the 6 guidance documents as well as other rapid response projects related to substance use and COVID-19.
The webinar will be held in French.
Register now!

Virtual Harm Reduction Symposium - Time's Up
2021-02-24 12:00 - 15:30
The Harm Reduction Symposium will bring together many stakeholders to raise awareness, educate, and enhance harm reduction collaboration.

CALL TO ACTION:
As a community, it is our responsibility to improve the lives of those impacted by problematic substance use. To achieve this, we need to reduce stigma, increase community collaboration, and influence systematic changes.

Impact of Drug Use in Canada:
The opioid crisis continues to claim the lives of Canadians. 17,602 apparent opioid-related deaths occurred between January 2016 and June 2020.
1,628 apparent opioid toxicity deaths occurred between April and June 2020, representing the highest quarterly count since national surveillance began in 2016.

In Canada, more than 12 deaths per day are due to the opioid crisis.
New Brunswick is reported to have the second highest prevalence of injection drug use in the country, second only to British Columbia. A large spike in overdose deaths has been observed as the COVID-19 pandemic has evolved and an increase in deaths among People Who Use Drugs (PWUD) has been felt across the country. This was also noted by the Saint John Police Force in mid-October. The warning was extended to advocacy groups in southern New Brunswick following several months of observation during the pandemic. In general, PWUD have been more vulnerable during the COVID-19 pandemic, due to poor health literacy and stigma and discrimination. In this setting there have been calls for decriminalization and increased access to safe supply.
It is time to encourage community capacity building to address these complex issues. The Harm Reduction Symposium will provide a platform to discuss innovative and sustainable approaches.
The 3rd annual Harm Reduction Symposium will bring together many stakeholders to raise awareness, educate, and enhance harm reduction collaboration.

French Language iOAT Webinar - Addiction and Mental health Ontario
2021-03-10 13:00 - 14:00
Injectable opioid agonist treatment (iOAT) is a safe, life-saving, and cost-effective treatment option for individuals with severe opioid dependence. It is also virtually unavailable in Ontario. The need for iOAT has never been greater given an opioid crisis that has become the most enduring public health emergency in recent Canadian history and further fueled by the COVID-19 pandemic.
Please join Addictions and Mental Health Ontario and presenters Brian Rush and April Furlong on March 10th, to discuss AMHO’s Health Canada funded project exploring the need for prescription diacetylmorphine in Ontario.
The French language webinar will take place from 1-2 pm, please register here: https://us02web.zoom.us/webinar/register/WN_MIr-OBl_SPyDacfdjs1tsg.

Atlantic Indigenous Health Conference 2021
2021-03-23 - 2021-03-25
The three day event, presented by the Atlantic Policy Congress of First Nations Chiefs Secretariat, will feature speakers from across Canada discussing the theme Walking Together Through a Health Crisis and also include the Honouring Our People Awards. While this free event is open to the public, please note that the content will be tailored to those in the Atlantic region and the event will take place in Atlantic Standard Time (AST).
Register Now!

VIRTUAL EVENT: SAFER SUPPLY
2021-03-23 13:00 - 17:00
Detailed program
Presentation of the Guide d’usage optimal – Méthadone et buprénorphine de l’INESSS
Presentation of the work conducted by the Équipe de soutien clinique et organisationnel en dépendance et itinérance on the use of once-daily slow-release morphine (MLLU) in OAT in Quebec.
Interdisciplinary Panel on Safer Supply and Use of the MLLU
Canadian Expert Panel – Case Studies

Target audience
For health and social services professionals

Speakers
Coming soon

Practical information
Registration is free but mandatory.

Stimulus Connect 11: Impact of the Pandemic on People Who Use Drugs
2021-03-24 13:00 - 15:00
Public health in Canada responded dramatically to the COVID-19 crisis and not the overdose crisis. Join us for the Impact of the Pandemic on People Who Use Drugs: Part 2 as we connect.

6e Colloque international francophone sur le traitement de la dépendance aux opioïdes
2021-03-25 09:00 - 11:00
L’Institut universitaire sur les dépendances du Centre intégré universitaire de santé et de services sociaux du Centre-Sud–de-l’Île-de-Montréal organise présentement la 6e édition du colloque international TDO (traitement de la dépendance aux opioïdes). Le colloque TDO6 a une grande portée dans toute la francophonie ; en Europe, en Afrique et ici au Canada.

Pour cette édition, le thème est  Dialogues entre science et savoirs expérientiels : L’implication des usagers et des pairs dans le traitement du trouble lié à l’usage d’opioïdes, sur fond de crise en Amérique du Nord.

Le prochain webinaire est prévu pour le 25 mars 2021 (9 h à 11 h HNE) sous le thème Par et pour ; la participation des experts concernés dans les soins, la planification et l’organisation des services.
Un premier webinaire a déjà eu lieu le 3 février dernier (disponible en rattrapage sur le site Web du colloque).

Commission on Narcotic Drugs
2021-04-12 - 2021-04-16
The Commission on Narcotic Drugs (CND) is the body mandated to develop drug policy at the global level and is the governing body of UNODC. The Commission will take place next week, from 12 to 16 April 2021 and, because of the pandemic, all commission proceedings will be available to watch on a live webcast. (Central European Time)
To listen to the live proceedings of the Commission, please visit the webcast page. General information and documentation on the 64th CND is available here.

Variations temporelles de l’injection de drogues et association avec le risque d’infection par le virus de l’hépatite C
2021-04-13 12:30 - 13:30
La majorité des personnes utilisatrices de drogues par injection (PUDI) contracteront le virus de l’hépatite C (VHC), les mettant à risque accru de complications hépatiques graves et parfois mortelles. Les comportements les plus risqués pour l’acquisition du VHC incluent le partage de matériel d’injection et l’injection à haute fréquence. Un facteur jusqu’ici négligé dans l’évaluation du risque d’infection par le VHC est l’aspect dynamique de l’injection, c.-à-d. la manière dont elle varie dans le temps, incluant l’effet des périodes sans injection et celui des changements dans la fréquence d’injection. On reconnaît également l’effet délétère que l’instabilité résidentielle peut avoir sur le risque d’infection par le VHC, bien que les mécanismes sous-jacents soient mal compris.
Cette thèse s’intéresse à l’effet des variations temporelles de l’injection sur le risque de VHC, et à la manière dont la fréquence d’injection évolue en concomitance avec les conditions résidentielles dans le temps, afin d’aider au développement de nouvelles stratégies de prévention du VHC. Collectivement, les résultats qui seront présentés ont de nombreuses implications en termes de prévention du VHC.
Conférencier:
Emmanuel Fortier, MD, PhD (cand.)
Emmanuel Fortier a fait ses études de médecine à l’Université de Montréal et a fait des stages en médecine et en psychiatrie des toxicomanies. Durant ses études de médecine, il a entrepris un MSc et un PhD dans l’équipe de Dre Julie Bruneau, en codirection avec Prof Jason Grebely du Kirby Institute en Australie.
Emmanuel est maintenant résident en psychiatrie à l’Université d’Ottawa. Il a déposé sa thèse de doctorat et il vient nous présenter ses travaux.
Inscrivez-vous gratuitement !

Journée de la recherche du DMFMU et du Réseau de recherche en soins primaires de l’UdeM (RRSPUM)
2021-04-14 08:00 - 16:45

Drug Use During Covid: A Harm Reduction Conversation
2021-04-17 13:00 - 14:30
Join the U.S.-based People of Color Psychedelic Collective for a Panel Discussion about harm reduction during Covid.
Participation is free!
For more information : http://bit.ly/pocharmredux

Trans-101 presentation/discussion with A.J. Lowik
2021-04-22 15:00 - 16:30
Come learn all about trans and non-binary people and communities! This session will cover key terminology and demystify pronouns. We will also talk about informational erasure and why there are so many gaps in our knowledge about trans people and substance use. We will identify some of the challenges of doing trans-inclusive substance use research, and discuss some of the ways that you can ensure that your research is inclusive to trans and non-binary people.

Learning Objectives
By the end of this session, you will be able to:
– define sex, gender, cisgender, transgender, cisnormativity, and transnormativity;
– understand the importance of pronouns, including knowing how to ask for someone’s pronouns, share your own, and knowing what to do when mistakes happen;
– understand some of the challenges of doing trans-inclusive substance use research; and,
– strategize solutions for overcoming some of those challenges to ensure that your research is as inclusive possible.

Bio
A.J. Lowik is a PhD Candidate with the Institute for Gender, Race, Sexuality and Social Justice at UBC. They are the Gender Equity Advisor with the Centre for Gender and Sexual Health Equity, where they are leading a medical education curricular audit looking at how medical students are being taught about the health care needs of intersex, trans, non-binary and Two-Spirit people. They are a Graduate Academic Assistant at the BC Centre on Substance Use, where their work critically interrogates how sex and gender variables are mobilized in substance use research. They are a Sessional Lecturer at the University of British Columbia, where they teach Intro to Trans Studies and Intersectional Approaches to Thinking Gender. A.J. is a non-binary trans person, a queer liberationist, an unapologetic feminist and a lover of cats, yoga and fibre arts.

Zoom
https://us04web.zoom.us/j/9733736174?pwd=[REDACTED]
ID: 973-373-6174
Password: [REDACTED]

Série de webinaires – COVID-19 et personnes en situation d'itinérance
2021-04-26 12:00 - 2021-04-29 13:30
Cette série de 4 webinaires présente des résultats de recherche de projets réalisés sur l’itinérance et la dépendance en contexte de pandémie.

La COVID : déclencheur d’un effet domino vers l’itinérance : Lundi 26 avril 2021 de 12h à 13h30
« Rien n’a vraiment changé, mais il n’y a plus rien de pareil » : le point de vue des personnes en situation d’itinérance sur les impacts de la COVID dans leur vie quotidienne : Mardi 27 avril 2021 de 12h à 13h30
La transformation des services et des pratiques en itinérance en temps de pandémie : le regard des intervenant.e.s et des gestionnaires : Mercredi 28 avril 2021 de 12h à 13h30
Crise sanitaire : Implantation de l’unité d’isolement COVID-19 du Royal Victoria de Montréal : Jeudi 29 avril 2021 de 12h à 13h30

Inscrivez-vous!

Mental Health Training Sessions - Centre d'études sur la réadaptation, le rétablissement et l'insertion sociale (CÉRRIS)
2021-04-28 08:00 - 17:00
CERRIS is offering free access for its pilot project : Recovery Collège en santé mentale . These trainings are open to all and accessible to the general public. This is the perfect opportunity to learn more about mental health and how to care for it.
Places are available in these different trainings (in French):
– Anxiété de performance chez les jeunes,
– Rétablissement 101,
– Parlons santé, parlons santé mentale,
– Regards sur la stigmatisation,
– Retrouver motivation, sens et collectif en télétravail/télé-études,
– La résilience: s’adapter et s’outiller pour mieux rebondir,
– Vers le bien-être: agir face au stress,
– Discutons Anxiété et Inquiétudes.
For more information and to know the different dates, consult this Linkedin post.

BC Substance Use Conference 2021
2021-06-16 08:00 - 2021-06-17 17:00
The 2021 BC Substance Use Conference is the third annual conference hosted by the BC Centre on Substance Use. This conference brings together stakeholders from across the province to share clinical expertise, lived experiences, and the latest evidence relating to substance use. This one-day virtual conference will include presentations and panels on research, education, and clinical care guidance.

Register now!

Stimulus Connect: Recognizing Expertise
2021-06-23 13:00 - 17:00
This Stimulus Connect will present the findings from the CAPUD Best Practices in Meaningful and Respectful Engagement of People Who Use Drugs, led by the Canadian Association of People who Use Drugs (CAPUD) and the Canadian Drug Policy Coalition. We will share the study findings, discuss the implications for organizations, and encourage self-reflection and self-assessment on the extent to which best practices have and should be implemented. Participants will be encouraged to thoughtfully consider the (mis)match between their good intentions, and the lived realities of PWUD who either work in harm reduction organizations, or attend conferences/meetings.
Register now!

Management of opioid use disorder with injectable opioid agonist treatment
2021-06-24 12:00 - 13:00
Presenters:
Dr. Rupi Brar, Interim Medical Director, Regional Addiction Program, VCH; Clinical Assistant Professor, UBC; Primary care – PHS Community Services Society; Addiction Medicine Consult Team, St Paul’s Hospital
Dr. Marie-Ève Goyer, Scientific Director of the Clinical and Organizational Support Team in Addiction and Homelessness; Assistant Professor, Family Medicine and Emergency Department, University of Montréal
Learning objectives:
1. Review the evidence for iOAT in treating opioid use disorder.
2. Incorporate iOAT as part of the continuum of care for opioid use disorder.
3. Evaluate patients for starting iOAT.
4. Safely initiate and titrate iOAT, and provide ongoing clinical support to a patient on iOAT.

Understanding Barriers to Treatment and Virtual Solutions in Addictions Services in PEI
2021-06-30 17:00 - 19:00
Presenters include:

People with lived experience (PWLE), researchers, and clinicians in PEI.

Topics covered include:

Substance use treatment needs identified through lived experience.
Research on barriers to treatment.
Virtual solutions to some of these barriers.
Combining knowledge to address ongoing challenges and direct next steps.

Register now!

Stimulus Connect: Make it Queer
2021-07-28 13:00 - 15:00
This Stimulus webinar is an opportunity to learn and connect on sexual and gender diverse communities and what good engagement looks like. This webinar is a foundational piece for a future Stimulus Connect that will discuss the harm reduction and drug policy issues that gender and sexually diverse people face.

Atlantic Indigenous Health Conference 2021
2021-10-05 09:00 - 2021-10-07 15:00
The conference, hosted by the Atlantic Policy Congress of First Nations Chiefs Secretariat, will take place over three days and include the Honouring Our People Awards.

IUPLSSS Conference: Cultural safety in the context of addiction rehabilitation: a case study (In French only)
2021-10-19 12:00 - 13:00 | Zoom, Québec, Canada
Our partner, l’Institut universitaire de première ligne en santé et services sociaux (IUPLSSS) is organising an online conference on the theme of cultural safety. Julie Lauzière will present her dissertation on Cultural Safety in Inuit Health Programs: A Case Study in the Context of Treatment for Psychoactive Substance Use Problems. This event is offered in French only.
Register here

Convention - The Clinical Management of Pain & Addiction (in-person & videoconference) (In French)
2021-11-11 | Hôtel Delta Québec, 690, boul. René-Lévesque Est, Québec, Québec, G1R 5A8, Canada
In collaboration with Fédération des médecins omnipraticiens du Québec (FMOQ) and Initiative de la Communauté de pratique médicale en dépendance (CPMD), this two-day convention aims to provide clinicians with the necessary knowledge and tools to be able to navigate issues related to addiction and chronic pain. This is an excellent opportunity to learn about two problems that are not often discussed in academia.
** Registration for the in-personal event is now full. However, it remains possible to participate via videoconference.

ISAM 2021 - Virtual Congress
2021-11-19 - 2021-11-21
The ISAM2021 Global Congress is the premier international event for healthcare professionals involved in the world of addiction. This year’s global congress will explore global solutions to international problems in the field of addiction medicine.
Dr. Jutras-Asward of the QA Node and his colleagues from the BC Node present their results of the completed OPTIMA study. This large-scale, multi-site interventional study evaluated and compared the effectiveness of two different models of care for the treatment of prescription opioid use disorders to improve patient care.
Click here to view the complete program schedule.

Webinar: La réglementation des TAO comme révélateur des évolutions des politiques sur les drogues
2022-02-24 11:00 - 13:30
L’Institut universitaire sur les dépendances of the Centre intégré universitaire de santé et de services sociaux du Centre-Sud–de-l’Île-de-Montréal is currently organising the 6th edition of the TDO international symposium. The TDO6 symposium has a wide reach throughout the Francophonie; in Europe, in Africa and here in Canada.
For this edition, the theme is Dialogues entre science et savoirs expérientiels : L’implication des usagers et des pairs dans le traitement du trouble lié à l’usage d’opioïdes, sur fond de crise en Amérique du Nord.
The next webinar is scheduled for February 24, 2022 (11:00 a.m. to 1:30 p.m. EST) under the theme: Par et pour ; la participation des experts concernés dans les soins, la planification et l’organisation des services.
A previous webinar has already taken place on October 28, 2021 on, Les réalités autochtones, (available on the conference website).

CAHR 2022 - Annual Canadian Conference on HIV/AIDS Research
2022-04-28 - 2022-05-01 | London (ontario), London, Ontario, Canada
The 31st Canadian Conference on HIV/AIDS Research (CAHR Conference) will be held virtually from April 28th to May 1st. Held each year since 1991, the CAHR Conference is an opportunity for researchers and community members from across Canada to share the latest scientific advances in the field, learn from one another’s expertise, build new skills and develop new ways to treat and prevent HIV.
More details: https://www.cahr-acrv.ca/conference/
Register by clicking here
